SCHEMBL7363512

SCHEMBL7363512

CC(C)CCCC(=O)N(O)C(=O)N[C@@H](Cc1ccccc1)C(=O)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 4/20 0.45
CYP2D6 P10635 2/20 0.45
MAPT P10636 1/20 0.45
MMP1 P03956 4/20 0.43
MMP2 P08253 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HDAC8 Q9BY41 2/20 0.42
PSMB1 P20618 2/20 0.42
PSMB5 P28074 2/20 0.42
PSMB2 P49721 2/20 0.42
MMP8 P22894 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
PSMB8 P28062 2/20 0.42
PSMB11 A5LHX3 1/20 0.42
PSMD11 O00231 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7360065 0.91 MMP1 (0.51) MMP3MMP1MMP2MMP8
SCHEMBL7357715 0.88 NPC1 (0.49) MMP1PSMB1PSMB5PSMB2MMP8
SCHEMBL7354243 0.88 NAALAD2 (0.52) MMP2
SCHEMBL8749847 0.88 NAALAD2 (0.52) MMP2
SCHEMBL7357691 0.86 CTSL (0.45) MMP3MMP1MMP2PSMB1PSMB5
SCHEMBL7364715 0.85 L3MBTL1 (0.45) MMP1MMP8
SCHEMBL7357664 0.85 ALDH1A1 (0.54) CYP2C9CYP2C19
SCHEMBL7357404 0.84 CHRNB2 (0.48)
SCHEMBL7358630 0.83 CTSL (0.43) MMP3MMP1MMP2HDAC8PSMB1
SCHEMBL6416222 0.83 MMP1 (0.39) MMP3MMP1MMP2MMP8MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0740652-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1998-05-06 EP claimed
EP-0740652-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1996-11-06 EP claimed
WO-1995019956-A1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1995-07-27 WO claimed
US-5919940-A TERT-LEUCINE-THIAZOL-2-YLAMIDE BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-07-06 US disclosed
US-5859253-A L-TERT-LEUCINE-2-PYRIDYLAMIDE BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1999-01-12 US disclosed
EP-0740652-B1 METALLOPROTEINASE INHIBITORS BRITISH BIOTECH PHARM (GB) 1998-05-06 EP disclosed
US-5747514-A Metalloproteinase inhibitors BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1998-05-05 US disclosed
US-5691382-A ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1997-11-25 US disclosed
EP-0667770-B1 INHIBITION OF TNF PRODUCTION BRITISH BIOTECH PHARM (GB) 1997-03-19 EP disclosed
EP-0667770-A1 INHIBITION OF TNF PRODUCTION. BRITISH BIOTECH PHARM (GB) 1995-08-23 EP disclosed
WO-1994010990-A1 INHIBITION OF TNF PRODUCTION BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) 1994-05-26 WO disclosed